Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$360K Sell
6,128
-105
-2% -$5.84K 0.08% 62
2019
Q3
$332K Sell
6,233
-66
-1% -$3.4K 0.21% 69
2019
Q2
$315K Sell
6,299
-1,147
-15% -$57.6K 0.21% 69
2019
Q1
$389K Buy
7,446
+557
+8% +$27.8K 0.27% 54
2018
Q4
$329K Buy
6,889
+203
+3% +$10K 0.24% 66
2018
Q3
$336K Sell
6,686
-438
-6% -$22.3K 0.21% 65
2018
Q2
$359K Buy
+7,124
New +$359K 0.23% 60

Other funds holding GSK

Landmark Bank's GSK Position: Q4 2019 in Review

Landmark Bank reduced its GSK (GSK) stake by 1.7% in Q4 2019, selling an estimated $5.84K and leaving 6,128 shares worth $360K. The position accounts for 0.08% of the portfolio, ranked #62.

Landmark Bank first reported a position in GSK in Q2 2018 and has held it in 7 quarters since. The position peaked at $389K in Q1 2019. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

  • Landmark Bank held 6,128 shares of GSK worth $360K as of Q4 2019.
  • Landmark Bank sold 105 GSK shares in Q4 2019, an estimated $5.84K.
  • GSK made up 0.08% of Landmark Bank's portfolio in Q4 2019, its #62 holding.
  • Landmark Bank first reported a position in GSK in Q2 2018 and has held it in 7 quarters since.
  • Landmark Bank's GSK position peaked at $389K in Q1 2019.
  • 894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Landmark Bank's 13F filing for Q4 2019, filed 12 Feb 2020.